Palliation in cyanotic congenital heart disease. Fifteen years' experience of various shunt procedures.
During the past 15 years, 143 systemic pulmonary shunt procedures have been performed in 117 patients. These have been evaluated for their clinical effectiveness, the need for a repeat operation and the mortality; particular attention was paid to the Teflon shunt. Variations were found in shunt performance, depending on the primary defect, the type of shunt that was employed and the year of operation. The overall shunt patency after three years was 77% (85% with the Teflon shunt). Although, in our total experience, mortality at 30 days was 12%, with 16% late deaths, "modified Blalock" (Teflon) shunts had only a 5% hospital mortality and a 5% late mortality within three years. Pulmonary atresia, without a ventricular septal defect, is often insufficiently palliated by a shunt alone. Ten of 82 patients with variations of the tetralogy complex died within 30 days of operation, and a further 11 died in the late follow-up period. Six of these 21 shunts were patent at autopsy. Less common defects, such as univentricular heart, transposition and double-outlet right ventricular connections, that are associated with pulmonary stenosis had no early mortality but led to four late deaths among 27 patients. Two of the four patients had patent shunts. Results in the early part of this experience were less than acceptable owing to inferior shunting techniques, postoperative management errors and, particularly, inadequate follow-up surveillance. With correction of these factors we find that the modified Blalock shunt provides very good early and late mortality results, with excellent clinical palliation and patency rates.
J
J
Wright
H
H
Albrecht
J
J
Beveridge
D000293:Adolescent; D000328:Adult; D001807:Blood Vessel Prosthesis / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D006083:Graft Occlusion, Vascular / Q000209:etiology; D006330:Heart Defects, Congenital / Q000401:mortality / Q000601:surgery*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010166:Palliative Care / Q000379:methods*; D011138:Polytetrafluoroethylene; D011651:Pulmonary Artery / Q000601:surgery; D012086:Reoperation; D012501:Saphenous Vein / Q000637:transplantation; D013348:Subclavian Artery / Q000601:surgery
D011138:Polytetrafluoroethylene